TY - JOUR
T1 - Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
AU - Huang, Brendan K.
AU - Elicker, Brett M.
AU - Henry, Travis S.
AU - Kallianos, Kimberly G.
AU - Hahn, Lewis D.
AU - Tang, Monica
AU - Heng, Franklin
AU - McCulloch, Charles E.
AU - Bhakta, Nirav R.
AU - Majumdar, Sharmila
AU - Choi, Jiwoong
AU - Denlinger, Loren C.
AU - Fain, Sean B.
AU - Hastie, Annette T.
AU - Hoffman, Eric A.
AU - Israel, Elliot
AU - Jarjour, Nizar N.
AU - Levy, Bruce D.
AU - Mauger, Dave T.
AU - Sumino, Kaharu
AU - Wenzel, Sally E.
AU - Castro, Mario
AU - Woodruff, Prescott G.
AU - Fahy, John V.
N1 - Publisher Copyright:
© 2024, Huang et al.
PY - 2024
Y1 - 2024
N2 - BACKGROUND. Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS. CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS. The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION. Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION. Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915.
AB - BACKGROUND. Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS. CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS. The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION. Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION. Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915.
UR - http://www.scopus.com/inward/record.url?scp=85184664626&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.174124
DO - 10.1172/jci.insight.174124
M3 - Article
C2 - 38127464
AN - SCOPUS:85184664626
SN - 2379-3708
VL - 9
JO - JCI Insight
JF - JCI Insight
IS - 3
M1 - e174124
ER -